About this episode

Dr. Neuen summarizes findings from his study on SGLT2 inhibition and its effects on hospitalizations in CKD patients.

In this podcast, Dr. Neuen summarizes the main findings from his study on "SGLT2 inhibition and hospitalizations in patients with CKD: Data from CREDENCE and a meta-analysis of CKD progression trials" on behalf of his colleagues.

People in this episode

Guest: Dr. Neuen

Topics covered

• SGLT2 inhibition
• chronic kidney disease
• hospitalizations
• CREDENCE study
• CKD progression trials

Keywords

• SGLT2
• chronic kidney disease
• hospitalizations
• CREDENCE
• meta-analysis
• CKD progression

Mentioned in this episode

Organizations: American Society of Nephrology

Books & works: SGLT2 inhibition and hospitalizations in patients with CKD: Data from CREDENCE and a meta-analysis of CKD progression trials

More episodes of Clinical Journal of the American Society of Nephrology (CJASN)

• Total Kidney Volume and eGFR in Polycystic Kidney Disease · May 18, 2026 · 4 min
• Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1 · March 18, 2026 · 4 min
• Finerenone and eGFR Slope · February 26, 2026 · 3 min
• Dynamic Risk Prediction of Deceased Donor Kidney Transplant Failure · February 18, 2026 · 4 min
• Early-Start vs. Late-Start Icodextrin in Pediatric Peritoneal Dialysis Patients · December 18, 2025 · 6 min
• Comparative Effectiveness of Lubiprostone and Stool Softeners in CKD · October 28, 2025 · 4 min

Explore listener stats, chart rankings, contacts and more on the Clinical Journal of the American Society of Nephrology (CJASN) podcast page.